{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:20Z","timestamp":1777984280068,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-025-03549-2","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:24:53Z","timestamp":1770427493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful management of IgE-mediated protamine allergy in cardiac surgery: bicentric case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Philippe","family":"Portran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Charvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Jacquet-Lagreze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Didier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Sebbag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Bensaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Fellahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"1","key":"3549_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1051\/ject\/201850005","volume":"50","author":"L Shore-Lesserson","year":"2018","unstructured":"Shore-Lesserson L, Baker RA, Ferraris V, Greilich PE, Fitzgerald D, Roman P, et al. STS\/SCA\/AmSECT clinical practice guidelines: anticoagulation during cardiopulmonary bypass. J Extra Corpor Technol Mars. 2018;50(1):5\u201318.","journal-title":"J Extra Corpor Technol Mars"},{"issue":"2","key":"3549_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1742-7843.2008.00274.x","volume":"103","author":"M Nybo","year":"2008","unstructured":"Nybo M, Madsen JS. Serious anaphylactic reactions due to Protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol ao\u00fbt. 2008;103(2):192\u20136.","journal-title":"Basic Clin Pharmacol Toxicol ao\u00fbt"},{"issue":"6","key":"3549_CR3","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1213\/00000539-200206000-00005","volume":"94","author":"SE Kimmel","year":"2002","unstructured":"Kimmel SE, Sekeres M, Berlin JA, Ellison N. Mortality and adverse events after Protamine administration in patients undergoing cardiopulmonary bypass. Anesth Analg Juin. 2002;94(6):1402\u20138. table of contents.","journal-title":"Anesth Analg Juin"},{"issue":"12","key":"3549_CR4","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1111\/j.1365-2222.2011.03825.x","volume":"41","author":"A Liu","year":"2011","unstructured":"Liu A, Fanning L, Chong H, Fernandez J, Sloane D, Sancho-Serra M, et al. Desensitization regimens for drug allergy: state of the Art in the 21st century. Clin Exp Allergy J Br Soc Allergy Clin Immunol d\u00e9c. 2011;41(12):1679\u201389.","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol d\u00e9c"},{"key":"3549_CR5","doi-asserted-by":"publisher","first-page":"101601","DOI":"10.1016\/j.trim.2022.101601","volume":"73","author":"YY He","year":"2022","unstructured":"He YY, Huang YP, Wang L, Song B. A case with no administration of Protamine to neutralize heparin in aortic valve replacement with cardiopulmonary bypass. Transpl Immunol ao\u00fbt. 2022;73:101601.","journal-title":"Transpl Immunol ao\u00fbt"},{"issue":"8","key":"3549_CR6","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1517\/14656566.6.8.1349","volume":"6","author":"TE Warkentin","year":"2005","unstructured":"Warkentin TE, Koster A. Bivalirudin: a review. Expert Opin Pharmacother Juill. 2005;6(8):1349\u201371.","journal-title":"Expert Opin Pharmacother Juill"},{"issue":"3","key":"3549_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1213\/ANE.0b013e3181e9ead3","volume":"111","author":"JK Wong","year":"2010","unstructured":"Wong JK, Tian Y, Shuttleworth P, Caffarelli AD, Reitz BA, Mora-Mangano CT. Case report: a thrombus in the venous reservoir while using bivalirudin in a patient with heparin-induced thrombocytopenia undergoing heart transplantation. Anesth Analg. 2010;111(3):609\u201312.","journal-title":"Anesth Analg"},{"issue":"2","key":"3549_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.thromres.2004.02.012","volume":"113","author":"IP Casserly","year":"2004","unstructured":"Casserly IP, Kereiakes DJ, Gray WA, Gibson PH, Lauer MA, Reginelli JP, et al. Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration. Thromb Res. 2004;113(2):115\u201321.","journal-title":"Thromb Res"},{"issue":"1","key":"3549_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/0970-9185.92458","volume":"28","author":"S Agarwal","year":"2012","unstructured":"Agarwal S, Ullom B, Al-Baghdadi Y, Okumura M. Challenges encountered with Argatroban anticoagulation during cardiopulmonary bypass. J Anaesthesiol Clin Pharmacol Janv. 2012;28(1):106\u201310.","journal-title":"J Anaesthesiol Clin Pharmacol Janv"},{"issue":"2","key":"3549_CR10","volume":"10","author":"AS McRae","year":"2022","unstructured":"McRae AS, Tidwell WP, Patel S, Lombard FW. Heparin desensitisation prior to cardiopulmonary bypass in a patient with alpha-gal allergy. Anesth Rep. 2022;10(2):e12203.","journal-title":"Anesth Rep"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-025-03549-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:11:16Z","timestamp":1773223876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12871-025-03549-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3549"],"URL":"https:\/\/doi.org\/10.1186\/s12871-025-03549-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7343795\/v1","asserted-by":"object"}]},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the policy of Hospices civils de Lyon and Centre hospitalo-universitaire Clermont-Ferrand ethical approval was not required for a case report. In France, the allocation and distribution of organs for transplantation are centrally managed by the French Biomedicine Agency under national legislation. In accordance with French law, the originating hospital of the donor organ cannot be disclosed. Organ donation in France is based on presumed consent: the national register of refusals is consulted and, if the individual is not listed, consent for organ donation is presumed. No organs or tissues were procured from prisoners or individuals under detention. All recipients provided informed consent for transplantation, and the procurement process complied with the Declaration of Helsinki and relevant national regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from both patients for publication of these case reports and accompanying clinical details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}